Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery

Fig. 1

Histologic examples of different extent of visual residual tumour cells (VRTC) in ESCC treated with neoadjuvant therapy and surgery (100×): a no VRTC: evident fibrosis and chronic inflammatory infiltrate without detectable tumor cells (TRG 1a according to Becker system or Grade 3 according to Japanese system); b little VRTC: fibrosis with rare small groups of tumor cells (TRG 1b according to Becker system or Grade 2 according to Japanese system); c many VRTC: fibrosis and tumor cells with preponderance of tumor cells; and d no regression response: no signs of treatment effect

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us